MainStreet Investment Advisors LLC Sells 6,004 Shares of UnitedHealth Group Incorporated $UNH

MainStreet Investment Advisors LLC cut its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 62.9% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 3,545 shares of the healthcare conglomerate’s stock after selling 6,004 shares during the quarter. MainStreet Investment Advisors LLC’s holdings in UnitedHealth Group were worth $1,224,000 at the end of the most recent quarter.

A number of other large investors have also bought and sold shares of the stock. Trajan Wealth LLC grew its holdings in shares of UnitedHealth Group by 33.9% in the third quarter. Trajan Wealth LLC now owns 85,293 shares of the healthcare conglomerate’s stock worth $29,452,000 after purchasing an additional 21,609 shares during the last quarter. Sound View Wealth Advisors Group LLC lifted its holdings in UnitedHealth Group by 41.6% in the 3rd quarter. Sound View Wealth Advisors Group LLC now owns 5,034 shares of the healthcare conglomerate’s stock worth $1,738,000 after buying an additional 1,479 shares during the period. Marks Group Wealth Management Inc raised its holdings in shares of UnitedHealth Group by 143.1% during the third quarter. Marks Group Wealth Management Inc now owns 47,802 shares of the healthcare conglomerate’s stock valued at $16,506,000 after acquiring an additional 28,142 shares in the last quarter. Intelligence Driven Advisers LLC lifted its holdings in UnitedHealth Group by 8.4% in the third quarter. Intelligence Driven Advisers LLC now owns 706 shares of the healthcare conglomerate’s stock worth $244,000 after buying an additional 55 shares during the period. Finally, X Square Capital LLC bought a new position in shares of UnitedHealth Group in the 3rd quarter worth approximately $1,036,000. 87.86% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

UNH has been the topic of several research reports. UBS Group dropped their price objective on shares of UnitedHealth Group from $430.00 to $410.00 and set a “buy” rating on the stock in a research note on Wednesday, January 28th. Piper Sandler reiterated an “overweight” rating on shares of UnitedHealth Group in a research note on Tuesday, January 27th. KeyCorp reissued an “overweight” rating on shares of UnitedHealth Group in a report on Wednesday, January 28th. JPMorgan Chase & Co. dropped their price objective on UnitedHealth Group from $425.00 to $389.00 and set an “overweight” rating on the stock in a research report on Monday, February 2nd. Finally, Deutsche Bank Aktiengesellschaft downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating and set a $333.00 target price for the company. in a research report on Wednesday, October 29th. One research analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating, nine have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, UnitedHealth Group has a consensus rating of “Moderate Buy” and an average target price of $372.13.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $290.11 on Monday. The stock has a 50-day simple moving average of $316.85 and a two-hundred day simple moving average of $325.30. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.82 and a current ratio of 0.79. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $606.36. The firm has a market capitalization of $262.79 billion, a PE ratio of 21.99, a P/E/G ratio of 1.33 and a beta of 0.41.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, January 27th. The healthcare conglomerate reported $2.11 earnings per share for the quarter, beating analysts’ consensus estimates of $2.09 by $0.02. UnitedHealth Group had a return on equity of 14.79% and a net margin of 2.69%.The firm had revenue of $113.22 billion for the quarter, compared to analysts’ expectations of $113.38 billion. During the same period in the previous year, the firm earned $6.81 EPS. The business’s quarterly revenue was up 12.3% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. Analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.